1416734-92-3

Basic information

• Product Name: C₁₉⁽¹¹⁾CH₂₂N₂O₃
• CAS NO: 1416734-92-3
• Molecular Weight: 337.395
• Mol File: 1416734-92-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₉⁽¹¹⁾CH₂₂N₂O₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₉⁽¹¹⁾CH₂₂N₂O₃(1416734-92-3)
• EPA Substance Registry System: C₁₉⁽¹¹⁾CH₂₂N₂O₃(1416734-92-3)

Safety Data

• Hazardous Substances Data: 1416734-92-3(Hazardous Substances Data)

Upstream product

• 449729-47-9 C₆⁽¹¹⁾CH₁₁NO 
• 681161-44-4 3′-hydroxy-(1,1′-biphenyl)-3-carboxamide 

Relevant articles and documents

Radiosynthesis and evaluation of [11C-carbonyl ]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography

Fatty acid amide hydrolase (FAAH) plays a key role in regulating the tone of the endocannabinoid system. Radiotracers are required to image and quantify FAAH activity in vivo. We have synthesized a series of potent FAAH inhibitors encompassing two classes of N-alkyl-O-arylcarbamates and radiolabeled eight of them with carbon-11. The [11C-carbonyl]-radiotracers were evaluated in vitro and ex vivo in rats as potential FAAH imaging agents for positron emission tomography (PET). Both sets of [11C]O-arylcarbamates showed good to excellent brain penetration and an appropriate regional distribution. Pretreatments with a FAAH inhibitor demonstrated that 80-95% of brain uptake of radioactivity constituted binding of the radiotracers to FAAH. Brain extraction measurements showed that binding to FAAH was irreversible and kinetically different for the two classes of carbamates. These promising results are discussed in terms of the requirements of a suitable radiotracer for the in vivo imaging of FAAH using PET.